[{"id":"04626dc2-433c-4bdb-b9e8-835957e85f73","acronym":"DB-1303-O-1001","url":"https://clinicaltrials.gov/study/NCT05150691","created_at":"2021-12-09T18:00:12.151Z","updated_at":"2025-02-25T13:54:07.926Z","phase":"Phase 1/2","brief_title":"A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05150691 - DB-1303-O-1001","lead_sponsor":"DualityBio Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive • HER-2 amplification • HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 amplification • HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Perjeta (pertuzumab) • trastuzumab pamirtecan (BNT323) • itraconazole • ritonavir"],"overall_status":"Recruiting","enrollment":" Enrollment 766","initiation":"Initiation: 01/31/2022","start_date":" 01/31/2022","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 10/01/2027","study_completion_date":" 10/01/2027","last_update_posted":"2024-10-03"},{"id":"ebecafeb-a52a-4612-a3a1-e15f416b0569","acronym":"A104","url":"https://clinicaltrials.gov/study/NCT03383692","created_at":"2021-01-17T17:24:32.434Z","updated_at":"2025-02-25T14:58:35.612Z","phase":"Phase 1","brief_title":"Study of DS-8201a for Participants With Advanced Solid Malignant Tumors","source_id_and_acronym":"NCT03383692 - A104","lead_sponsor":"Daiichi Sankyo Co., Ltd.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Enhertu (fam-trastuzumab deruxtecan-nxki) • itraconazole • ritonavir"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 01/12/2018","start_date":" 01/12/2018","primary_txt":" Primary completion: 09/26/2018","primary_completion_date":" 09/26/2018","study_txt":" Completion: 09/11/2023","study_completion_date":" 09/11/2023","last_update_posted":"2023-12-11"},{"id":"230a4eb0-75f1-40c7-9045-a482f4f529d7","acronym":"","url":"https://clinicaltrials.gov/study/NCT01609933","created_at":"2021-01-18T06:53:33.286Z","updated_at":"2024-07-02T16:37:09.955Z","phase":"Phase 2","brief_title":"A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study","source_id_and_acronym":"NCT01609933","lead_sponsor":"AbbVie (prior sponsor, Abbott)","biomarkers":" IFNA1","pipe":"","alterations":" ","tags":["IFNA1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ritonavir"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 12/18/2012","start_date":" 12/18/2012","primary_txt":" Primary completion: 05/03/2017","primary_completion_date":" 05/03/2017","study_txt":" Completion: 05/03/2017","study_completion_date":" 05/03/2017","last_update_posted":"2018-06-19"},{"id":"10d15577-1976-4637-a837-428e95cca323","acronym":"","url":"https://clinicaltrials.gov/study/NCT01009437","created_at":"2021-01-18T03:56:59.867Z","updated_at":"2024-07-02T16:37:15.831Z","phase":"Phase 1/2","brief_title":"Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer","source_id_and_acronym":"NCT01009437","lead_sponsor":"Masonic Cancer Center, University of Minnesota","biomarkers":" HER-2 • ER • PGR • IL6 • TNFA • STAT3 • HSPA5 • ATF4 • HSP90AA1","pipe":" | ","alterations":" ER positive • HER-2 negative","tags":["HER-2 • ER • PGR • IL6 • TNFA • STAT3 • HSPA5 • ATF4 • HSP90AA1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ritonavir"],"overall_status":"Completed","enrollment":" Enrollment 28","initiation":"Initiation: 05/26/2010","start_date":" 05/26/2010","primary_txt":" Primary completion: 07/01/2014","primary_completion_date":" 07/01/2014","study_txt":" Completion: 07/01/2014","study_completion_date":" 07/01/2014","last_update_posted":"2017-12-05"}]